IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vestor who wrote (754)	4/26/1997 11:08:00 AM
From: Brad C. Dunlap	of 1762

Hi Vestor, it doesn't matter if you have an account with ML, since no analyst is going to communicate info to any ML broker or any unnecessary personell before a particular analyst comes out with a recommendation. I quess if the analyst had no plans to recommend then you might be able to inquire as to the specific reasons. If this behavior took place the respective firm would be in violation of front running. As discussed earlier, I strongly believe that ML would have one potential compliance problem if they were to recommend Idec and then sell their large holdings into the recommendation. If Idec were not to be successfull this would be a tough situation to defend in arbitration or court. Once ML is finished selling[they should be close] then it should be interesting to see what Hecht does in this lousy biotech envirenment. The only thing that I can say is that when Hecht was at Morgan he carried a strong buy recommendation and now that he is at Merrill it should be interesting to watch and wait to see what takes place.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next